Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

A GLP-1 oral medication claims to cut the risk of cardiovascular complications, like heart attacks and strokes, by 14% for people with diabetes and heart or kidney disease, per CNBC.

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...

Wegovy was also associated with a lower risk of hospitalization for heart failure, cardiovascular-related death, and ...

Jeremy Clarkson has updated fans on the challenging side effects of his attempts at weight loss as he reels from last year's ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

Among patients with diabetes and peripheral artery disease, semaglutide 1 mg increased walking distance vs. placebo, ...

Losing weight is a common New Year’s resolution, and many people are now turning to advanced weight-loss medications like ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

Studies have shown that Ozempic not only lowers blood sugar and insulin levels but also improves cardiovascular outcomes.

A study in the Journal of the American Heart Association found drinking two or more cups of coffee daily may double the risk of heart death in people with severe hypertension.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...